Bernhard Lämmle
#149,064
Most Influential Person Now
Researcher
Bernhard Lämmle's AcademicInfluence.com Rankings
Bernhard Lämmlecomputer-science Degrees
Computer Science
#7711
World Rank
#8116
Historical Rank
Computational Linguistics
#1593
World Rank
#1610
Historical Rank
Machine Learning
#2945
World Rank
#2982
Historical Rank
Artificial Intelligence
#3239
World Rank
#3287
Historical Rank

Download Badge
Computer Science
Bernhard Lämmle's Degrees
- PhD Computer Science ETH Zurich
- Masters Computer Science University of Zurich
- Bachelors Computer Science University of Zurich
Similar Degrees You Can Earn
Why Is Bernhard Lämmle Influential?
(Suggest an Edit or Addition)Bernhard Lämmle's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. (1998) (1596)
- Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. (1996) (890)
- ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. (2003) (667)
- Survival and relapse in patients with thrombotic thrombocytopenic purpura. (2010) (498)
- von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. (2011) (374)
- Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura (1997) (365)
- Severe COVID-19 infection associated with endothelial activation (2020) (363)
- Partial amino acid sequence of purified von Willebrand factor-cleaving protease. (2001) (356)
- Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. (1998) (326)
- Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies (2017) (325)
- Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. (2007) (325)
- This article has been cited by other articles (2003) (323)
- Assay of von Willebrand Factor (vWF)-cleaving Protease Based on Decreased Collagen Binding Affinity of Degraded vWF (1999) (323)
- The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency (2005) (312)
- Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. (2002) (311)
- ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. (2005) (275)
- Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. (2001) (269)
- Elevated nucleosome levels in systemic inflammation and sepsis* (2003) (244)
- Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. (2012) (238)
- Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). (2002) (223)
- Association of two silent polymorphisms of platelet glycoprotein la/lla receptor with risk of myocardial infarction: a case-control study (1999) (217)
- Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura. (2004) (216)
- Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. (1997) (196)
- Recovery and Half-Life of von Willebrand Factor-Cleaving Protease after Plasma Therapy in Patients with Thrombotic Thrombocytopenic Purpura (1999) (190)
- Thromboembolism and Bleeding Tendency in Congenital Factor XII DeficienCy - A Study on 74 Subjects from 14 Swiss Families (1991) (180)
- ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock (2007) (159)
- Thrombotic Risk of Women with Hereditary Antithrombin III-, Protein C- and Protein S-Deficiency Taking Oral Contraceptive Medication (1994) (154)
- Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin. (2005) (151)
- Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. (2013) (149)
- Thrombotic thrombocytopenic purpura (2017) (144)
- Reevaluation of the Incidence of Thromboembolic Complications in Congenital Factor XII Deficiency (1999) (136)
- Ten years of prophylactic treatment with fresh‐frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor‐cleaving protease (2001) (120)
- Plasma DNA is Elevated in Patients with Deep Vein Thrombosis. (2013) (113)
- Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura (2009) (110)
- Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction. (1999) (109)
- ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor‐cleaving protease activity by recombinant human ADAMTS13 (2003) (106)
- Impaired DNase1‐mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies (2015) (103)
- Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. (1986) (101)
- Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2. (2017) (99)
- C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction (2002) (98)
- Measurement of von Willebrand factor‐cleaving protease (ADAMTS‐13) activity in plasma: a multicenter comparison of different assay methods (2003) (93)
- Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis (1997) (89)
- von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience. (2004) (89)
- Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic‐uremic syndromes (2010) (88)
- Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor‐cleaving protease (2001) (86)
- Measurement of ADAMTS‐13 activity in plasma by the FRETS‐VWF73 assay: comparison with other assay methods (2006) (84)
- Von Willebrand Factor in Thrombotic Thrombocytopenic Purpura (1999) (84)
- Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers. (1993) (83)
- Accuracy of d‐dimer/fibrinogen ratio to predict pulmonary embolism: a prospective diagnostic study (2003) (81)
- Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. (2012) (80)
- Initial experience from a double‐blind, placebo‐controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura (2012) (78)
- Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study. (2017) (78)
- Thrombotic thrombocytopenic purpura (2005) (77)
- Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. (2007) (77)
- Protein Z in ischaemic stroke (2001) (76)
- Cognitive deficits after recovery from thrombotic thrombocytopenic purpura (2009) (75)
- Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism (2013) (75)
- Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura (2012) (74)
- A common origin of the 4143insA ADAMTS13 mutation (2006) (73)
- The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017 (2019) (72)
- Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome, 1996 to 2011 (CME) (2012) (71)
- Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B. (1996) (71)
- Fifteen Coagulation and Fibrinolysis Parameters in Diabetes Mellitus and in Patients with Vasculopathy (1984) (70)
- Platelets: thrombotic thrombocytopenic purpura. (2002) (70)
- Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia. (2003) (70)
- ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients (2020) (69)
- Hyperbilirubinemia interferes with ADAMTS‐13 activity measurement by FRETS‐VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies (2007) (67)
- Von Willebrand Factor-cleaving Protease in Childhood Diarrhoea-associated Haemolytic Uraemic Syndrome (2001) (67)
- Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins. (2004) (66)
- Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura. (2004) (65)
- Sporadic bloody diarrhoea‐associated thrombotic thrombocytopenic purpura‐haemolytic uraemic syndrome: an adult and paediatric comparison (2008) (63)
- Frequency of protein Z deficiency in patients with ischaemic stroke (2001) (63)
- D-Dimers Predict Stroke Subtype when Assessed Early (2009) (62)
- Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). (1984) (61)
- Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. (2002) (60)
- Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients (2012) (60)
- Polypharmacy is Associated with an Increased Risk of Bleeding in Elderly Patients with Venous Thromboembolism (2015) (58)
- Immunoblotting studies of the molecular forms of protein C in plasma. (1988) (58)
- Mutations in the human factor XII gene. (1997) (58)
- Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis (2020) (58)
- Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13) (2008) (58)
- The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology (2013) (57)
- Protein C replacement in severe meningococcemia: rationale and clinical experience. (2001) (56)
- Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management (2021) (55)
- ADAMTS13 activity in sickle cell disease (2006) (53)
- Protein Z in healthy human individuals and in patients with a bleeding tendency (1998) (53)
- Treatment of thrombotic thrombocytopenic purpura (1983) (53)
- Evaluation of a Platelet Function Analyser (PFA-100) in patients with a bleeding tendency. (2002) (51)
- Prekallikrein deficiency: the characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII. (2002) (51)
- Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. (2014) (51)
- Effect of low-molecular weight dextran sulfate on coagulation and platelet function tests. (2002) (50)
- Coagulation factor XII Locarno: the functional defect is caused by the amino acid substitution Arg 353-->Pro leading to loss of a kallikrein cleavage site. (1994) (50)
- Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems (2003) (50)
- Von Willebrand factor – cleaving protease ( ADAMTS 13 ) in thrombocytopenic disorders : a severely deficient activity is specific for thrombotic thrombocytopenic purpura (2002) (50)
- Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. (2009) (49)
- Formation of the fibrin clot: the balance of procoagulant and inhibitory factors. (1985) (47)
- Rapid D-dimer testing and pre-test clinical probability in the exclusion of deep venous thrombosis in symptomatic outpatients (2001) (47)
- Factor XII clotting activity and antigen levels in patients with thromboembolic disease (1992) (47)
- High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence (2016) (46)
- No association of APC resistance with myocardial infarction. (1995) (45)
- 16 Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura (1998) (45)
- The Oklahoma Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome Registry: the Swiss connection (2008) (44)
- Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory. (2003) (44)
- SimpliRED D-dimer Assay: Comparability of Capillary and Citrated Venous Whole Blood, Between-assay Variability, and Performance of the Test for Exclusion of Deep Vein Thrombosis in Symptomatic Outpatients (1998) (44)
- Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency. (2004) (42)
- Is Plasminogen Deficiency a Thrombotic Risk Factor ? – A Study on 23 Thrombophilic Patients and their Family Members (1998) (41)
- A frameshift mutation in Exon V of the A alpha-chain gene leading to truncated A alpha-chains in the homozygous dysfibrinogen Milano III. (1994) (41)
- Mycobacterium genavense infection in a patient with long‐standing chronic lymphocytic leukaemia (2000) (39)
- Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. (2012) (39)
- The splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs. (2014) (39)
- Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry (2013) (38)
- Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura. (2020) (37)
- Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients. (2009) (37)
- Platelet Aggregation, β-Thromboglobulin and Platelet Factor 4 in Diabetes Mellitus and in Patients with Vasculopathy (1984) (36)
- Plasma protein C inhibitor is elevated in survivors of myocardial infarction. (1997) (36)
- Detection and Quantitation of Cleaved and Uncleaved High Molecular Weight Kininogen in Plasma by Ligand Blotting with Radiolabeled Plasma Prekallikrein or Factor XI (1988) (35)
- Monitoring of heparin treatment. Comparison of thrombin time, activated partial thromboplastin time, and plasma heparin concentration, and analysis of the behavior of antithrombin III. (1980) (35)
- Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura--new insights into underlying biochemical mechanisms. (2000) (34)
- Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease (2008) (34)
- Depression and cognitive deficits as long‐term consequences of thrombotic thrombocytopenic purpura (2017) (33)
- Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis (2007) (33)
- Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature. (2007) (32)
- Prospective comparison of clinical prognostic scores in elder patients with a pulmonary embolism (2012) (32)
- Heparin-dependent in vitro aggregation of normal platelets by plasma of a patient with heparin-induced skin necrosis: specific diagnostic test for a rare side effect. (1988) (31)
- Purified Human Plasma Kallikrein Does Not Stimulate but Primes Neutrophils for Superoxide Production (1989) (31)
- Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma. (1986) (30)
- Low molecular weight heparin‐induced thrombocytopenia and skin necrosis distant from injection sites (1994) (30)
- Binding of alpha-thrombin to fibrin depends on the quality of the fibrin network. (1994) (30)
- Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura. (1998) (29)
- Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency (2011) (29)
- Thromboembolism in patients with congenital afibrinogenaemia (2016) (29)
- Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism (2018) (29)
- New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: case report and review (1999) (29)
- The novel acceptor splice site mutation 11396(G-->A) in the factor XII gene causes a truncated transcript in cross-reacting material negative patients. (1995) (28)
- Factor XIII in severe sepsis and septic shock. (2007) (27)
- Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura. (2002) (27)
- Variability of anti‐PF4/heparin antibody results obtained by the rapid testing system ID‐H/PF4‐PaGIA (2009) (27)
- The von Willebrand Factor-Cleaving Protease (ADAMTS-13) and the Diagnosis of Thrombotic Thrombocytopenic Purpura (TTP) (2003) (27)
- Quantitative Immunoblotting of Plasma and Platelet Protein S (1986) (25)
- Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus. (2001) (25)
- A new substitution, gamma 358 Ser-->Cys, in fibrinogen Milano VII causes defective fibrin polymerization. (1994) (25)
- A first case of congenital TTP on the African continent due to a new homozygous mutation in the catalytic domain of ADAMTS13 (2008) (24)
- Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancy. (2015) (24)
- Usefulness of the D‐dimer/fibrinogen ratio to predict deep venous thrombosis (2005) (24)
- 1,25(OH)2 vitamin D3 in osteoporosis--a pilot study. (1979) (23)
- Contact phase of blood coagulation is not activated in edema of high altitude. (1989) (22)
- Genetic Predisposition to Bleeding during Oral Anticoagulant Therapy: Evidence for Common Founder Mutations (FIXVal-10 and FIXThr-10) and an Independent CpG Hotspot Mutation (FIXThr-10) (2001) (22)
- Quantitative immunoblotting assay of blood coagulation factor XII. (1986) (22)
- Performance of a New Fibrin Monomer Assay to Exclude Deep Vein Thrombosis in Symptomatic Outpatients (1999) (21)
- Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin–α2-antiplasmin complex is an independent predictor of coronary re-events (2001) (21)
- Influence of Low Molecular Weight Heparin and Low Molecular Weight Dextran Sulfate on the Inhibition of Coagulation Factor XIa by Serpins (1998) (21)
- Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab (2018) (20)
- The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications (2014) (20)
- Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study (2016) (20)
- Amidolytic activity in normal human plasma assessed with chromogenic substrates. (1979) (20)
- Hemophilia A Pseudoaneurysm in a Patient with High Responding Inhibitors Complicating Total Knee Arthroplasty: Embolization: A Cost-Reducing Alternative to Medical Therapy (2006) (20)
- Bilateral periorbital ecchymoses (2014) (20)
- Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine (2015) (19)
- Images in clinical medicine. Capnocytophaga canimorsus sepsis. (2009) (19)
- Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients. (2018) (19)
- Annual Incidence and Severity of Acute Episodes in Hereditary Thrombotic Thrombocytopenic Purpura. (2021) (19)
- von Willebrand factor and factor VIII in renal transplant recipients under immunosuppression with cyclosporine and steroids. Sequential measurements over 4 months in 17 patients. (1990) (19)
- Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency (2016) (19)
- The Contact Phase of Blood Coagulation in Diabetes Mellitus and in Patients with Vasculopathy (1984) (18)
- How high is the true fibrinogen content of fibrinogen standards? (1989) (18)
- Derivation and validation of a novel bleeding risk score for elderly patients with venous thromboembolism on extended anticoagulation. (2017) (18)
- Cold Promoted Activation and Factor XII, Prekallikrein and C1-Inhibitor (1985) (18)
- Subcutaneous low-molecular-weight heparin for treatment of Trousseau’s syndrome (1997) (17)
- Functional characterization of an abnormal factor XII molecule (F XII Bern). (1991) (17)
- Depressive Symptoms as a Novel Risk Factor for Recurrent Venous Thromboembolism: A Longitudinal Observational Study in Patients Referred for Thrombophilia Investigation (2015) (17)
- Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction. (2004) (17)
- Severe plasma prekallikrein deficiency: Clinical characteristics, novel KLKB1 mutations, and estimated prevalence (2020) (16)
- Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution. (1994) (16)
- [Hemostasis parameters in 55 patients with venous and/or arterial thromboembolisms]. (1989) (16)
- Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen. (1987) (16)
- Splenectomy in thrombotic thrombocytopenic purpura (2000) (15)
- IFNα treatment in systemic mastocytosis (1999) (15)
- Agreement of D-dimer Results Measured by a Rapid ELISA (VIDAS) before and after Storage during 24 h or Transportation of the Original Whole Blood Samples (2000) (15)
- Functional Characterization of a Variant Prekallikrein (PK Zürich) (1993) (15)
- Rumpel–Leede sign in thrombocytopenia due to Epstein–Barr virus‐induced mononucleosis (2010) (15)
- Contact system activation in human sepsis - 47kD HK, a marker of sepsis severity? (2008) (15)
- High Molecular Weight Kininogen Is Cleaved by FXIa at Three Sites: Arg409-Arg410, Lys502-Thr503 and Lys325-Lys326 (2000) (14)
- IFNalpha treatment in systemic mastocytosis. (1999) (14)
- Normal Binding of Calcium to Five Fibrinogen Variants with Mutations in the Carboxy Terminal Part of the γ-Chain (1996) (14)
- Improved detection of proteolytically cleaved high molecular weight kininogen by immunoblotting using an antiserum against its reduced 47 kDa light chain (1995) (14)
- Hemostatic risk factors in ischemic stroke (2003) (13)
- A quantitative dot immunobinding assay for coagulation factor XII in plasma. (1990) (13)
- Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome. (2019) (13)
- Monitoring of Oral Anticoagulation by an Amidolytic Factor X Assay (1980) (13)
- Characterization of Five Homozygous ADAMTS13 Mutations in Hereditary Thrombotic Thrombocytopenic Purpura – Towards a Phenotype-Genotype Correlation? (2008) (13)
- Plasminogen Deficiency: An Additional Risk Factor for Thrombosis in a Family with Factor V R506Q Mutation? (1996) (13)
- Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients. (2011) (12)
- Immunogenic hotspots in the spacer domain of ADAMTS13 in immune‐mediated thrombotic thrombocytopenic purpura (2020) (12)
- Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research Study (2016) (12)
- Functional Characterization of a Variant Factor XII (F XII Locarno) in a Cross Reacting Material Positive F XII Deficient Plasma (1992) (12)
- Heparin Cofactor II: Purification and Antibody Production (1986) (12)
- Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain. (1999) (11)
- Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+) (2013) (11)
- Is factor V Leiden a risk factor for thrombotic microangiopathies without severe ADAMTS13 deficiency? (2005) (11)
- [Measurement of bleeding time and study of thrombocyte aggregation. Standardization of methods, normal values and results in patients with suspected hemorrhagic diathesis]. (1988) (11)
- Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? (2017) (10)
- No Evidence for Classic Thrombotic Microangiopathy in COVID-19 (2021) (10)
- Concomitant treatment with lamivudine renders cladribine inactive by inhibition of its phosphorylation (2009) (10)
- Is factor V Leiden a risk factor for thrombotic microangiopathies without severe ADAMTS 13 deficiency? (2005) (10)
- The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial (2020) (10)
- [Systemic chronic juvenile arthritis (Still's disease) in adults. Review of the literature]. (1983) (9)
- Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization (1993) (9)
- Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene (2014) (9)
- Chronic interstitial nephritis in Whipple's disease (1983) (9)
- Predicting Risk for Relapse in Patients Who Have Recovered from Thrombotic Thrombocytopenic Purpura (TTP). (2006) (8)
- Thrombotic Thrombocytopenic Purpura (TTP) and Systemic Lupus Erythematosus (SLE): Distinct but Potentially Overlapping Syndromes. (2004) (8)
- Discrepant activity levels of von Willebrand factor-cleaving protease (ADAMTS-13) in congenital thrombotic thrombocytopenic purpura. (2003) (8)
- Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC). (1984) (8)
- Neurocognitive Impairment Following Recovery from ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP). (2007) (8)
- Decreased Free Protein S Levels in Polycythemia Vera (1990) (8)
- [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation]. (1998) (8)
- Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired α2-antiplasmin deficiency associated with AL amyloidosis (2009) (8)
- Standardized Management Protocol in Severe Postpartum Hemorrhage: A Single-Center Study (2018) (7)
- Different Assessment of Plasmin with Different Substrates (1980) (7)
- The ADAMTS13 Gene as the Immunological Culprit in Acute Acquired TTP - First Evidence of Genetic Out-Breeding Depression in Humans. (2007) (7)
- Warning: Simplate II -Lack of Standardization in Standardized Bleeding Time Devices (1990) (7)
- Assay of Factor XII clotting activity in heparinized plasma. (1983) (7)
- Biocompatibility in transfusion medicine. (1996) (7)
- c.451dupT in KLKB1 is common in Nigerians, confirming a higher prevalence of severe prekallikrein deficiency in Africans compared to Europeans (2020) (7)
- Binding of calcium ions and their effect on clotting of fibrinogen Milano III, a variant with truncated Aα‐chains (1996) (7)
- Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura (2014) (7)
- Plasma prekallikrein determination. (1982) (6)
- [Patient self-monitoring of oral anticoagulation with CoaguChek]. (2000) (6)
- Treatment with stanozolol before thrombolysis in patients with arterial occlusions. (1985) (6)
- [Control of oral anticoagulation: comparison between Quick and colorimetric factor X determination in 107 patients]. (1979) (6)
- Major coagulation disorders when using aprotinin--observations on a case. (1991) (6)
- Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization. (1993) (6)
- [Criteria for hemostasis in kidney transplant patients. Comparison of patients undergoing immunosuppression with cyclosporin and azathioprine steroids]. (1984) (6)
- Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura. (2021) (5)
- In vitro rescue of FGA deletion by lentiviral transduction of an afibrinogenemic patient's hepatocytes (2014) (5)
- Phenprocoumon-induced hepatitis delaying precise diagnosis in a thrombophilic patient with activated protein C resistance due to factor V R506Q mutation. (1997) (5)
- Derivation and validation of a novel bleeding risk score for elderly patients with venous thromboembolism on extended anticoagulation (2017) (5)
- Case 5: Prolonged thrombin time in a patient with multiple myeloma (1999) (5)
- Determination of thrombin-antithrombin-III-complex is not a suitable screening test for detecting deficiency of protein C or protein S. (1992) (5)
- Venous thrombosis after Caesarean section in a young woman with homozygous APC resistance and type I protein S deficiency (1997) (5)
- ADAMTS13 gene variants and function in women with preeclampsia: a population- based nested case- control study from the HUNT Study. (2015) (5)
- Fibrinogen St. Gallen I (γ 292 Gly → Val): Evidence for Structural Alterations Causing Defective Polymerization and Fibrinogenolysis (1999) (5)
- Increased fibrin monomer plasma concentration in stable coronary artery disease in patients without oral anticoagulation. (2001) (5)
- Diagnostic Criteria for Hematopoietic Stem Cell Transplantation-Associated Microangiopathy (TAM): Results of a Consensus Process by an International Working Group. (2005) (5)
- Evidence for a Pathophysiological Role of Anti-ADAMTS13 Antibodies Despite the Presence of Normal ADAMTS13 Activity and Presumption of an Epitope Spreading over Time in Recurrent Thrombotic Thrombocytopenic Purpura (TTP). (2006) (4)
- Animal models of thrombotic thrombocytopenic purpura: the tales from zebrafish (2020) (4)
- The Amidolytic Prekallikrein (PK) Determination: Enhanced PK Activation After Deep-Freezing of Patients' Plasmas (1983) (4)
- Cold Agglutinin Syndrome and Liver Transplantation (1994) (4)
- Fibrinogen Claro--another dysfunctional fibrinogen variant with gamma 275 arginine-->histidine substitution. (1996) (4)
- More on: thrombosis and ELISA optical density values in hospitalized patients with heparin‐induced thrombocytopenia (2005) (4)
- Haemorrhagic Shock Nine Days after Extracorporeal Shock Wave Lithotripsy in a Patient with Haemophilia B (1988) (4)
- Purified Factor XII Has a Higher Specific Activity than the Parent Molecule in Plasma (1991) (4)
- hemoglobin ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by Fatal congenital thrombotic thrombocytopenic purpura with apparent (2013) (4)
- A Randomized, Double-Blind, Placebo-Controlled, Clinical Outcome Study of ARC1779 In Patients with Thrombotic Thrombocytopenic Purpura (TTP) (2010) (4)
- Acute pancreatitis and thrombotic thrombocytopenic purpura. (2008) (4)
- Methodology and clinical significance of heparin cofactor II. Probable heparin cofactor II deficiency in a patient with cerebrovascular thrombosis. (1985) (4)
- [Clinical problems with oral anticoagulation -- 3 case reports]. (2003) (4)
- Fibrinogen Milano XIII (Aalpha 19 Arg-->Gly): a dysfunctional variant with an amino acid substitution in the N-terminal polymerization site. (1999) (4)
- Immunogold labelling of human von Willebrand factor adsorbed to collagen (1991) (4)
- Thrombotic microangiopathy: Caplacizumab accelerates resolution of acute acquired TTP (2016) (4)
- [Unexpectedly prolonged thrombin time]. (1993) (4)
- [Chronic, hemorrhage-induced iron deficiency anemia in Osler disease]. (1999) (3)
- [Comparison of a sensitive rabbit brain thromboplastin and a human placenta thromboplastin for thromboplastin time determination]. (1989) (3)
- [Autoimmune polyendocrinopathy with IGA deficiency]. (1978) (3)
- May-Thurner syndrome: missed diagnosis and missed early treatment? (2017) (3)
- [Thrombotic thrombocytopenic purpura--an often missed diagnosis]. (2014) (3)
- Risk stratification of elderly patients with acute pulmonary embolism (2019) (3)
- [Decreased Quick percentage, acquired factor X deficiency, hemarthrosis and ecchymosis: amyloidosis]. (1999) (3)
- Acquired von Willebrand syndrome in myeloproliferative disorder (2003) (3)
- Severe Depression Following Recovery From Thrombotic Thrombocytopenic Purpura (TTP) (2012) (3)
- [A patient with isolated prolongation of aPTT without hemorrhagic diathesis anamnesis: severe, hereditary factor XII deficiency]. (1999) (3)
- DOSING LEPIRUDIN IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA AND VARIOUS DEGREES OF RENAL FUNCTION IMPAIRMENT (2007) (3)
- Tryptase from human mast cells does not activate purified human Hageman Factor (1988) (3)
- Clinical problems with oral anticoagulant treatment – three case reports (2003) (3)
- Case 10: A patient with an isolated prolongation of the activated partial thromboplastin time without a bleeding problem – severe hereditary Factor XII deficiency (1999) (3)
- Influence of Personality, Resilience and Life Conditions on Depression and Anxiety in 104 Patients Having Survived Acute Autoimmune Thrombotic Thrombocytopenic Purpura (2021) (3)
- Fibrinogen Milano XIII (Aα 19 Arg→Gly) (1999) (3)
- Factor XII, Plasma Prekallikrein, α2-Macroglobulin and C1-Inhibitor Levels in Renal Allograft Recipients During Immunosuppression with Cyclosporin A – Sequential Measurements over Four Months in 17 Patients (1987) (3)
- [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys]. (1991) (3)
- Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura (2015) (3)
- Thrombotic thrombocytopenic purpura. (2005) (3)
- Amidolytic Prekallikrein (PK) Assay: Unsuitability of Cephotest® as an Activator (1984) (3)
- [46-year-old woman with multiple hematomas and bleeding of the base of the tongue: phenprocoumon poisoning]. (1999) (3)
- purpura Survival and relapse in patients with thrombotic thrombocytopenic (2011) (2)
- History of Thrombotic Thrombocytopenic Purpura and the von Willebrand Factor–Cleaving Protease, ADAMTS13 (2015) (2)
- Reply to Rebuttal: von Willebrand Factor-cleaving Protease in Childhood Diarrhoea-associated Haemolytic Uraemic Syndrome (2002) (2)
- [Contribution of the hemostasis laboratory in the diagnosis of deep venous thrombosis]. (1996) (2)
- Case 14: Prolonged prothrombin time, acquired factor X deficiency, hemarthrosis and skin bleeding – Amyloidosis (1999) (2)
- Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: Pathophysiology and Differentiation from Graft versus Host Disease (2019) (2)
- [Hyperparathyroidism. Quantitative determination of specific skeletal changes in the radiography of the hand]. (1977) (2)
- Clinical Problem Solving and Using New Paths in the Laboratory: Learning from Case Studies (2020) (2)
- 167. Nachuntersuchungen bei 100 Patienten mit operativ gesichertem primarem Hyperparathyreoidismus (1978) (2)
- A new tool to further explore the role of ADAMTS‐13 in health and disease (2006) (2)
- Long-Term Follow-Up of 21 Patients with Thrombotic Thrombocytopenic Purpura (TTP) and Severe ADAMTS13 Deficiency: Demonstration of Persistent ADAMTS13 Deficiency and Neurocognitive Abnormalities. (2004) (2)
- Diagnosis of Hereditary TTP Caused by Homozygosity for a Rare Complex ADAMTS13 Allele After Salmonella Infection in a 43-Year-Old Asylum Seeker (2021) (2)
- Activation of the contact system in patients with sepsis and with septic shock. (1997) (2)
- VERLANGERTE THROMBINZEIT - MULTIPLES MYELOM (1999) (2)
- [Prevention of venous thromboembolism--in whom, when and how?]. (1994) (2)
- Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency (2003) (2)
- Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy in Acquired TTP Is the Expression of a General Dysregulation of the Immune Response, (2011) (2)
- Screening for lupus anticoagulant: improving the performance of the lupus‐sensitive PTT‐LA (2011) (2)
- [Severe hemorrhage, lymphocytosis and leukoerythroblastic blood picture--disseminated intravascular coagulation in metastatic prostate carcinoma and chronic lymphatic leukemia]. (1999) (2)
- Mortality and Morbidities During Long-Term Follow-up After Recovery From Thrombotic Thrombocytopenic Purpura (TTP) (2012) (2)
- International Registry for Patients with Hereditary Thrombotic Thrombocytopenic Purpura (TTP) – Upshaw-Schulman Syndrome (2012) (2)
- [Acute hyperkalemia and non-oliguric kidney failure during treatment with indomethacin, allopurinol, nifedipine, hydrochlorothiazide/amiloride, trimethoprim/sulfamethoxazole and acetylsalicylic acid]. (1988) (2)
- In Vitro Effects of the Acylated StreptokinasePlasminogen Activator Complex BRL 33 575 Incubated with Normal Human Plasma (1984) (2)
- [Still's disease in adults. 2 case reports]. (1983) (2)
- [Fibrinolysis therapy in massive lung embolism. Experiences in 10 patients 1982-1984]. (1985) (2)
- Plasmin Inhibitors and Fibrinogen Breakdown During the Initial Phase of Thrombolytic Treatment - The Problem of the α2-Antiplasmin Determination (1984) (2)
- Polyendocrine deficiency syndrome. Occurrence in a patient with depressed IgA titers receiving phenytoin. (1980) (2)
- Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: Another case of factor IX propeptide mutation (2011) (2)
- Opana ER-induced thrombotic microangiopathy. (2017) (2)
- [Increased thrombin time in a patient with multiple myeloma]. (1999) (2)
- Variability of anti‐PF4/heparin antibody results obtained by the rapid testing system ID‐H/PF4‐PaGIA: reply to a rebuttal (2009) (2)
- Stealth thrombosis of brain and kidney in a girl with Upshaw–Schulman syndrome not receiving prophylactic plasma infusions (2020) (2)
- Control of Heparin Treatment with three Different Methods. Behaviour of Antithrombin III (1979) (2)
- Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease. (2003) (2)
- [Internal bleeding in patients on oral anticoagulants]. (1993) (1)
- [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation]. (1981) (1)
- Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature (2008) (1)
- [The significance of APC resistance (activated protein C) for clinical practice]. (1997) (1)
- Severe High Molecular Weight Kininogen (HK) Deficiency: Clinical Characteristics, Deficiency-Causing KNG1 Variants in Reported and New Cases, and Estimated Prevalence (2021) (1)
- Sporadic Bloody Diarrhea-Associated Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) in Adults in Oklahoma: Comparison to Adults with Severe Adamts13 Deficiency and to Children with Typical HUS. (2007) (1)
- Prevalence of depression in patients with diagnosis of thrombotic thrombocytopenic purpura (TTP) (2015) (1)
- [Life-long hemorrhagic diathesis in a young man with unclottable global coagulation tests--congenital afibrinogenemia]. (1999) (1)
- [A frequent problem in the laboratory control of heparinization: contamination of blood specimens with exogenous heparin]. (1984) (1)
- Apoptosis In Sepsis And Multiple Organ Dysfunction Syndrome (2004) (1)
- Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature (2018) (1)
- The Frequency of Rheumatic Disease Autoantibodies in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP). (2007) (1)
- Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura (2021) (1)
- The Incidence of TTP-HUS: Racial Disparity among Patients with Severe ADAMTS13 Deficiency. (2004) (1)
- [An infant with umbilical cord and intracranial hemorrhage--severe factor XIII deficiency]. (1999) (1)
- [Derailed oral anticoagulation with very high INR values and poor response to oral vitamin K--cholestasis as a possible cause]. (1999) (1)
- Definite diagnosis of plasma prekallikrein deficiency should not be based exclusively on shortening of the aPTT upon prolonged pre‐incubation (2022) (1)
- Case 15: Chronic bleeding anemia and Osler’s disease (1999) (1)
- Hemophagocytic Lymphohistiocytosis in Early Infancy- Pitfall of Differentiation between Hereditary and Infectious Reasons (2018) (1)
- Clinical Outcomes in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura (TTP) Who Received Platelet Transfusions (PT). (2007) (1)
- Polymerization of fibrin monomers results in increased thrombin binding (1990) (1)
- antibodies kininogen in human plasma by immunoblotting with monoclonal Detection of in vitro and in vivo cleavage of high molecular weight (2011) (1)
- Qualitative platelet defect and thrombohaemorrhagic complications in a patient with polycythaemia vera (2003) (1)
- [Temporal arteritis in a patient with long-standing migraine]. (1988) (1)
- [Systemic thrombolysis of arterial occlusions of the lower extremities. Comparison of various treatment schedules]. (1983) (1)
- Malondialdehyde formation by blood platelets: a diagnostic test to assess acetylsalicylic acid induced thrombocytopathy? (1990) (1)
- [Evaluating the origin of thrombophilia: indications and implementation]. (1992) (1)
- Primärer Hyperparathyreoidismus — Semiquantitative Erfassung der Fibroosteoklasie und des Knochenumsatzes im Handröntgenbild (1979) (1)
- Special Issue: “The Latest Clinical Advances in Thrombocytopenia” (2021) (0)
- Genotype-Phenotype Correlation in Congenital TTP: New Insights from a Multicentre Study with 121 Patients (2018) (0)
- Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry (2019) (0)
- Komplexe Gerinnungsstörungen (2010) (0)
- Thrombophilia and outcomes of venous thromboembolism in older patients (2022) (0)
- Prekallikrein Activator - Reply (1984) (0)
- Hemostatic risk factors in ischemic stroke Franziska (2018) (0)
- Inferior vena cava thrombosis in a child with nephroblastoma and combined deficiency of antithrombin III and free protein S (1990) (0)
- DETECTION AND QUANTITATION OF CLEAVED AND UNCLEAVED HIGH MOLECULAR WEIGHT KININOGEN IN PLASMA BY LIGAND BLOTTING WITH RADIOLABELED PLASMA PREKALLIKREIN OR FACTOR XI (1987) (0)
- Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) in Adults Following a Prodrome of Bloody Diarrhea. (2004) (0)
- Circulating Nucleosomes Reflect Disease Activity in Patients with Thrombotic Microangiopathies. (2010) (0)
- Thrombotic microangiopathies (2013) (0)
- Das Bild der femme fatale im Film Noir am Beispiel der Filme "The Maltese Falcon" und "Double Indemnity" (2008) (0)
- Are Patients Who Have Recovered From ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP) at Risk for Developing Systemic Lupus Erythematosus (SLE)? (2010) (0)
- [Interaction: Modifast--oral anticoagulation]. (1983) (0)
- More severe ADAMTS13 Deficiency in Homozygous versus Compound Heterozygous Carriers of the ADAMTS13 c.4143_4144dupA Mutation in Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Impact on Disease Onset? (2019) (0)
- Comments on 'Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody' by Reddigari and Kaplan. (1989) (0)
- Endothelial Dysfunction, Atherosclerosis, and Increase of Von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in Swine (2021) (0)
- Neonatal exchange transfusion: hereditary thrombotic thrombocytopenic purpura (hTTP) should be in the differential diagnosis (2023) (0)
- Pancreatitis Preceding Acute Episodes of Thrombotic Thrombocytopenic Purpura: Report of Five Patients with a Systematic Review of Published Reports. (2006) (0)
- Rebuttal to the Letter of F. Rodeghiero et al. -Thrombosis in Subjects with Homozygous and Heterozygous Factor XII Deficiency (1992) (0)
- COLD AGGLUTINING SYNDROME AND LIVER TRANSPLANTATION (1994) (0)
- Le purpura thrombotique thrombocytopénique - un diagtnostic méconnu (2014) (0)
- Rebuttal to the Letter to the Editor by W. P. M. Houdijk (1991) (0)
- Laboratory studies on 8 platelet concentrates prepared by plateletcell™ separator (1990) (0)
- Congratulations to Toshiyuki Miyata, PhD (2022) (0)
- Long-Term Renal Outcomes in Hereditary TTP Patients: Data from the International Hereditary TTP Registry (2021) (0)
- Title Pages / Table of Contents (2011) (0)
- Continuing Medical Education Program in Transfusion (2012) (0)
- Factor V Leiden Is Not a Risk Factor for Thrombotic Microangiopathies without Severe ADAMTS13 Deficiency. (2004) (0)
- High Molecular Weight Kininogen Is Cleaved by FXIa at Three Sites: Arg<sup>409</sup> -Arg<sup>410</sup> , Lys<sup>502</sup> -Thr<sup>503</sup> and Lys<sup>325</sup> -Lys<sup>326</sup> (2017) (0)
- Biological individuality and the new frontiers of immunological tolerance in hematopoietic stem cell transplantation (2010) (0)
- THROMBOSIS AND HEMOSTASIS The splenic autoimmune response to ADAMTS 13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR 3 motifs (2014) (0)
- ADAMTS13 Activity in Sickle Cell Disease: A Role in the Development of Clinical Vaso-Occlusion?. (2004) (0)
- Case 7: APC resistance – the most frequent hereditary thrombophilia (1999) (0)
- Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research (2021) (0)
- [Primary hyperparathyroidism--bone turnover and osteitis fibrosa assessed by x-ray (author's transl)]. (1979) (0)
- On the dosing of lepirudin. (2011) (0)
- thrombotic thrombocytopenic purpura thrombocytopenic disorders: a severely deficient activity is specific for cleaving protease (ADAMTS13) in - Von Willebrand factor (2013) (0)
- A third form of thrombotic thrombocytopenic purpura? (2022) (0)
- Influence of Thrombotic Thrombocytopenic Purpura on Depressivity, Cognitive Conduction, Quality of Life, and Resilience of Patients (2020) (0)
- in a prospective cohort of 142 patients uremic syndrome: relation to presenting features and clinical outcomes hemolytic - ADAMTS13 activity in thrombotic thrombocytopenic purpura (2013) (0)
- Long-Term Outcomes of Renal Function in Patients with TTP Associated with Severe ADAMTS13 Deficiency (2011) (0)
- Conclusion from 50 years of reports on prekallikrein or high-molecular-weight kininogen deficiency (2023) (0)
- Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine (2015) (0)
- P1528: GENETIC AND PHENOTYPIC CHARACTERIZATION OF HEREDITARY SPHEROCYTOSIS AND RELATED DISORDERS – DESCRIPTION OF 9 NEW GENETIC VARIANTS (2022) (0)
- Hereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection in this rare disease (2022) (0)
- Pearls, guidelines & more (2014) (0)
- Chronically Elevated Interleukin-6 Disturbs the Coagulation Cascade in Mice (2021) (0)
- Contents Vol. 33 (2003) (0)
- [Pathophysiology and surgery of the parathyroid glands]. (1978) (0)
- [APC resistance--most frequent familial thrombophilia]. (1999) (0)
- Shifted Haemostatic Balance in Patients with Recurrent Venous or Arteral Thrombosis (1979) (0)
- A Pathophysiological Role for ADAMTS13 in Thrombotic Thrombocytopenic Purpura (TTP) without Severe ADAMTS13 Deficiency. (2006) (0)
- Severe high-molecular-weight kininogen deficiency: clinical characteristics, deficiency-causing KNG1 variants, and estimated prevalence. (2022) (0)
- FACTOR XII, PLASMA PREKALLIKREIN ,α2-MACROGLOBULIN AND C1-INHIBITOR LEVELS IN RENAL ALLOGRAFT RECIPIENTS DURING IMMUNOSUPPRESSION WITH CYCLOSPORIN A (1987) (0)
- [Thromboembolic diseases from the hematologic viewpoint: 13 case examples]. (1992) (0)
- Founder Effect of the Factor-IX-Propeptide-Val-10 Variant Is Responsible for Most Marcumar-lnduced Severe Haemophilia B Cases During Oral Anticoagulant Therapy — Consequences for Monitoring (1999) (0)
- Mi ta bisa – mi ta skirbi? – Komplexe Satzstrukturen einer Kreolsprache im Ausbau: Satzverknüpfungstechniken des Papiamentu auf Curaçao (2014) (0)
- Acquired von Willebrand syndrome in a myeloproliferative disorder. Case 6. (2003) (0)
- FACTOR VIII:C (F VIII:C) AND VON WILLEBRAND FACTOR ANTIGEN (vWFag) IN RENAL TRANSPLANT RECIPIENTS IMMUNOSUPPRESSED WITH CYCLOSPORIN A (CyA) (1987) (0)
- [Venous thromboembolism in pregnancy and puerperium: pathophysiology, therapy, prevention]. (1991) (0)
- VWF and complement. (2015) (0)
- Absolute and Relative Blood Lymphocyte Subset Counts before and during Treatment of Patients with Thrombotic Thrombocytopenic Purpura (TTP). (2006) (0)
- The Von Willebrand factor multimer ratio and inflammatory markers in autoimmune thrombotic thrombocytopenic purpura (2023) (0)
- Comment on “Worldwide Distribution of PK Deficiency: the Defect Seems Mainly Concentrated in West African Countries and the United States” (2021) (0)
- Restricted Immunglobulin Gene Usage of Spleen-Derived Specific Anti-ADAMTS13 B-Cells In Relapsing TTP Treated with or without Rituximab. (2010) (0)
- Thrombotic thrombocytopenic purpura and pregnancy (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bernhard Lämmle?
Bernhard Lämmle is affiliated with the following schools: